
Dr. Ian Elliott Krop MD PHD
Oncologist | Medical Oncology
44 Binney St Dana 740 Dana Farber Boston MA, 02115About
Dr. Ian Krop is an oncologist practicing in Boston, MA. Dr. Krop specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Krop manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Johns Hopkins Univ Sch of Med, Baltimore Md 1996
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A SAGE (serial analysis of gene expression) view of breast tumor progression.
- HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
- Chemokine signaling in gliomas: prognostic factor, therapeutic target or both?
- Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.
- Mechanisms of trastuzumab resistance in breast cancer.
- Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists.
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.
- Advances in targeting SRC in the treatment of breast cancer and other solid malignancies.
- A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer.
- Trastuzumab emtansine for HER2-positive advanced breast cancer.
- A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer.
- Targeted therapies: HER2-positive breast cancer-sifting through many good options.
- Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.
- A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.
- New research on the treatment of small HER2-positive breast cancers.
Clinical Trials
Dr. Ian Elliott Krop MD PHD's Practice location
Ian Krop
44 Binney St Dana 740 Dana Farber -Boston, MA 02115Get Direction
Dr. Ian Elliott Krop MD PHD's reviews
Write ReviewPatient Experience with Dr. Krop
Recommended Articles
- Treatments for Liver Cancer
During liver cancer treatment, different healthcare professionals work together to come up with an overall treatment plan. The treatment plan combines different types of cancer treatment to get a successful cure. This group of doctors is called a "multidisciplinary team", which include:...
- He Found A Lump in His Breast. But That Didn’t Stop Him.
62-year-old Eric Passmore from Franklin, Indiana is a father, grandfather, and retired machinist. He is also a breast cancer survivor. ...
- New Cancer Therapy Shows Promise to Treat a Rare Type of Lymphoma
A new treatment for cancer, called checkpoint inhibitors, are showing promise with several types of cancer, including a rare type of lymphoma, called gray zone lymphoma.Immune checkpoint inhibitors are drugs produced by pharmaceutical companies that are often made of antibodies. Researchers are...
- Study Finds Risks of Damage to the Ovaries from Chemotherapy For Hodgkin’s Lymphoma in Women 35 and Older
It is well known that chemotherapy drugs work by warding off cancer cells or stopping them from multiplying. However, they can also affect some of the healthy cells within the body. This, in turn, can cause unwanted side effects, such as reduced fertility. The likeliness of one’s fertility being...
- Ovarian Cancer: Why a Second Opinion Is Essential
You know how crucial early detection is when it comes to ovarian cancer. Eighty-five percent of the time when women are diagnosed they are at a late stage and have a decreased likelihood of survival.The fact that this diagnosis needs to come quickly is the first area of concern. There isn’t much...
- Report Finds Primary Care Programs for Cancer Survivors Are Lacking
‘Cancer survivor’ is a term that is commonly used in medical literature, where survivorship begins from diagnosis and initial treatment, to cure, cancer-free survival, and long-term follow-up care. Cancer survivors are becoming a fast growing population in the United States. According to the...
Nearby Providers
- Dr. Timothy P. Cooley M.D.820 Harrison Avenue Boston Massachusetts 2118
- Nadine M. Tung330 Brookline Avenue Boston Massachusetts 2215
- Dr. Geoffrey I. Shapiro MD PHD450 Brookline Avenue Boston Massachusetts 07715
- Arthur T. Skarin44 Biney Street Boston Massachusetts 02115
- Dr. Osama E. Rahma M.D.450 BROOKLINE AVE BOSTON MA 02215
- Dr. Karen H Antman M.D.715 Albany St Boston MA 02118
Nearest Hospitals
BRIGHAM AND WOMEN'S HOSPITALl
75 FRANCIS STREET BOSTON MA 2115BOSTON CHILDREN'S HOSPITALl
300 LONGWOOD AVENUE BOSTON MA 2115